Combination of Copeptin and Troponin Assays to Rapidly Rule Out Non‐ST Elevation Myocardial Infarction in the Emergency Department
- 17 May 2012
- journal article
- clinical trial
- Published by Wiley in Academic Emergency Medicine
- Vol. 19 (5) , 517-524
Abstract
ACADEMIC EMERGENCY MEDICINE 2012; 19: 517–524 © 2012 by the Society for Academic Emergency Medicine Objectives: The aim of this study was to analyze the diagnostic accuracy and the clinical usefulness of the combination of troponin I (cTnI) and copeptin measured at presentation with an automated assay to rapidly rule out non‐ST elevation myocardial infarction (NSTEMI) in patients with suspected cardiac chest pain presenting to an emergency department (ED).Methods: This study was an ancillary analysis of a prospective observational study. Copeptin and cTnI levels were sampled at presentation in 641 consecutive patients admitted to the ED for chest pain with onset within the last 12 hours and without ST elevation on a 12‐lead electrocardiogram (ECG). Copeptin was measured with an automated assay and troponin with conventional assay. The performance of a combination of cTnI and copeptin for NSTEMI diagnosis was studied, the clinical utility was assessed by multivariate analysis, and an area under the curve (AUC) calculation was used to determine accuracy.Results: NSTEMI was diagnosed in 95 patients (15%). The sensitivity and negative predictive value (NPV) of the combination of copeptin and cTnI measures were 90.4% (95% confidence interval [CI] = 88.2% to 92.7%) and 97.6% (95% CI = 96.4% to 98.7%) versus 55.3% (95% CI = 51.5% to 59.2%) and 92.8% (95% CI = 90.8% to 94.8%) with cTnI alone. The AUC of the combination of copeptin and cTnI was 0.89 (95% CI = 0.85% to 0.92%) and was significantly higher than the AUC of cTnI alone (0.77, 95% CI = 0.72% to 0.82%, p < 0.05). The patient classification was slightly improved when copeptin was added to the usual diagnostic tools used for NSTEMI management.Conclusions: In this study, determination of copeptin, in addition to cTnI, improves early diagnostic accuracy of NSTEMI. However, the sensitivity of this combination even using a conventional troponin assay remains insufficient to safely rule out NSTEMI at the time of presentation.Keywords
This publication has 34 references indexed in Scilit:
- Combination of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction: A pilot studyArchives of Cardiovascular Diseases, 2011
- Biomarkers in acute myocardial infarctionBMC Medicine, 2010
- Comparison of Usefulness of Heart-Type Fatty Acid Binding Protein Versus Cardiac Troponin T for Diagnosis of Acute Myocardial InfarctionThe American Journal of Cardiology, 2009
- The Association Between Emergency Department Crowding and Adverse Cardiovascular Outcomes in Patients with Chest PainAcademic Emergency Medicine, 2009
- The Effect of Emergency Department Crowding on Clinically Oriented OutcomesAcademic Emergency Medicine, 2008
- Relationship between a Clear-cut Alternative Noncardiac Diagnosis and 30-day Outcome in Emergency Department Patients with Chest PainAcademic Emergency Medicine, 2007
- Relationship between a Clear‐cut Alternative Noncardiac Diagnosis and 30‐day Outcome in Emergency Department Patients with Chest PainAcademic Emergency Medicine, 2007
- Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of VasopressinClinical Chemistry, 2006
- Hypothalamo–pituitary–adrenal axis response to coronary artery embolization: an ovine model of acute myocardial infarctionJournal of Endocrinology, 1997
- Plasma corticotrophin releasing hormone, vasopressin, ACTH and Cortisol responses to acute myocardial infarctionClinical Endocrinology, 1994